Search research articles
Contact Us
Filters
Showing results (41-50 of 147) with videos related to
Page
of 15
Sort By:
American Journal of Clinical Pathology
|
February 10, 2018
Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast Cancers and Clinical Implications
Jing He, Lei Huo, Junsheng Ma, et al.
Biomedicines
|
October 23, 2021
ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells
Bora Lim, Christine B Peterson, Alexander Davis, et al.
Plos One
|
November 12, 2020
Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy
James Crespo, Hongxia Sun, Jimin Wu, et al.
The Surgical Clinics of North America
|
July 15, 2018
Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer
Arjun Menta, Tamer M Fouad, Anthony Lucci, et al.
Frontiers in Oncology
|
September 15, 2025
Case Report: Successful delivery following chemotherapy in a pregnant patient with metastatic SMARCB1-deficient renal medullary carcinoma
Panayiotis D Kontoyiannis, Adam Kuykendal, Chad Tang, et al.
Cancer Biology & Therapy
|
November 11, 2015
Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites
Wafik S El-Deiry, Namrata Vijayvergia, Joanne Xiu, et al.
Human Pathology
|
August 7, 2021
Clinicopathological features of and neoadjuvant therapy for human epidermal growth factor receptor 2-positive classic invasive lobular carcinoma
Xiao Huang, Hui Chen, QingQing Ding, et al.
Breast Cancer Research and Treatment
|
April 16, 2019
Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer
Jangsoon Lee, Bora Lim, Troy Pearson, et al.
Annals of Surgical Oncology
|
July 26, 2020
Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?
Lauren M Postlewait, Mediget Teshome, Sarah M DeSnyder, et al.
Journal of Cancer
|
December 8, 2015
Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer
Jangsoon Lee, Rachael Galloway, Geoff Grandjean, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 147) with videos related to
Sort By:
Page
of 15
American Journal of Clinical Pathology
|
February 10, 2018
Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast Cancers and Clinical Implications
Jing He, Lei Huo, Junsheng Ma, et al.
Biomedicines
|
October 23, 2021
ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells
Bora Lim, Christine B Peterson, Alexander Davis, et al.
Plos One
|
November 12, 2020
Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy
James Crespo, Hongxia Sun, Jimin Wu, et al.
The Surgical Clinics of North America
|
July 15, 2018
Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer
Arjun Menta, Tamer M Fouad, Anthony Lucci, et al.
Frontiers in Oncology
|
September 15, 2025
Case Report: Successful delivery following chemotherapy in a pregnant patient with metastatic SMARCB1-deficient renal medullary carcinoma
Panayiotis D Kontoyiannis, Adam Kuykendal, Chad Tang, et al.
Cancer Biology & Therapy
|
November 11, 2015
Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites
Wafik S El-Deiry, Namrata Vijayvergia, Joanne Xiu, et al.
Human Pathology
|
August 7, 2021
Clinicopathological features of and neoadjuvant therapy for human epidermal growth factor receptor 2-positive classic invasive lobular carcinoma
Xiao Huang, Hui Chen, QingQing Ding, et al.
Breast Cancer Research and Treatment
|
April 16, 2019
Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer
Jangsoon Lee, Bora Lim, Troy Pearson, et al.
Annals of Surgical Oncology
|
July 26, 2020
Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?
Lauren M Postlewait, Mediget Teshome, Sarah M DeSnyder, et al.
Journal of Cancer
|
December 8, 2015
Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer
Jangsoon Lee, Rachael Galloway, Geoff Grandjean, et al.
Page
of 15